Moderna, Inc. SEC filings MRNA
Moderna, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Mar 30, 2021. Its latest annual report, Form ARS, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 31, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 30, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 30, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Sep 1, 2026 | Aug 27, 2026 |
| 10-Q | Quarterly report | Jul 31, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 31, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 8, 2026 | Jul 6, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 11, 2026 | May 6, 2026 |
| 10-Q | Quarterly report | May 1, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 1, 2026 | May 1, 2026 |
| DEFA14A | Additional proxy material | Mar 16, 2026 | — |
| DEF 14A | Proxy statement | Mar 16, 2026 | May 6, 2026 |
| ARS | Annual report to shareholders | Mar 16, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement
|
Mar 5, 2026 | Mar 3, 2026 |
| S-8 | Employee stock plan registration | Feb 20, 2026 | — |
| 10-K | Annual report | Feb 20, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 13, 2026 | Feb 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 11, 2026 | Feb 3, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 5, 2026 | Jan 5, 2026 |
| SC TO-I/A | Filing | Dec 16, 2025 | — |
| 8-K |
Current report
Material agreement, New debt
|
Nov 24, 2025 | Nov 19, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 20, 2025 | Nov 20, 2025 |
| SC TO-I/A | Filing | Nov 18, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Nov 13, 2025 | Nov 12, 2025 |
| SC TO-I | Filing | Nov 13, 2025 | — |
| SC TO-C | Filing | Nov 12, 2025 | — |
| SC TO-C | Filing | Nov 6, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| SC TO-C | Filing | Oct 21, 2025 | — |
| DEFA14A | Additional proxy material | Oct 20, 2025 | — |
| DEF 14A | Proxy statement | Oct 15, 2025 | Nov 12, 2025 |
| SC TO-C | Filing | Oct 10, 2025 | — |
| SC TO-C | Filing | Oct 3, 2025 | — |
| PRE 14A | Preliminary proxy statement | Oct 3, 2025 | Nov 12, 2025 |
| 10-Q | Quarterly report | Aug 1, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2025 | Aug 1, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 5, 2025 | Apr 30, 2025 |
| 10-Q | Quarterly report | May 1, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 1, 2025 | May 1, 2025 |
| DEFA14A | Additional proxy material | Mar 11, 2025 | — |
| DEF 14A | Proxy statement | Mar 11, 2025 | Apr 30, 2025 |
| ARS | Annual report to shareholders | Mar 11, 2025 | Dec 31, 2024 |
| S-8 | Employee stock plan registration | Feb 21, 2025 | — |
| 10-K | Annual report | Feb 21, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 14, 2025 | Feb 14, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 2, 2024 | Sep 28, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 12, 2024 | Sep 12, 2024 |
| 10-Q | Quarterly report | Aug 1, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 23, 2024 | Jul 19, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 9, 2024 | May 6, 2024 |
| 10-Q | Quarterly report | May 2, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 2, 2024 | May 2, 2024 |
| DEFA14A | Additional proxy material | Mar 21, 2024 | — |
| DEF 14A | Proxy statement | Mar 21, 2024 | May 6, 2024 |
| ARS | Annual report to shareholders | Mar 15, 2024 | Dec 31, 2023 |
| PRE 14A | Preliminary proxy statement | Mar 11, 2024 | May 6, 2024 |
| S-8 | Employee stock plan registration | Feb 23, 2024 | — |
| 10-K | Annual report | Feb 23, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 22, 2024 | Feb 22, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 12, 2023 | Dec 8, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 6, 2023 | Nov 6, 2023 |
| 10-Q | Quarterly report | Nov 3, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 16, 2023 | Oct 16, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 11, 2023 | Sep 11, 2023 |
| 10-Q | Quarterly report | Aug 3, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 5, 2023 | May 3, 2023 |
| S-3ASR | Automatic shelf registration | May 5, 2023 | — |
| UPLOAD | Letter from the SEC | May 5, 2023 | — |
| 10-Q | Quarterly report | May 4, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 4, 2023 | May 4, 2023 |
| CORRESP | Letter to the SEC | Apr 28, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 20, 2023 | — |
| DEFA14A | Additional proxy material | Apr 14, 2023 | — |
| PX14A6G | Filing | Apr 13, 2023 | — |
| DEFA14A | Additional proxy material | Mar 15, 2023 | — |
| DEF 14A | Proxy statement | Mar 15, 2023 | — |
| ARS | Annual report to shareholders | Feb 27, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 24, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 23, 2023 | Feb 23, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 3, 2023 | Jan 3, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 13, 2022 | Dec 13, 2022 |
| 10-Q | Quarterly report | Nov 3, 2022 | Sep 30, 2022 |
| 8-K | Current report | Nov 3, 2022 | Nov 3, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 29, 2022 | Sep 29, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 17, 2022 | Aug 15, 2022 |
| 10-Q | Quarterly report | Aug 3, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2022 | Aug 3, 2022 |
| 8-K/A |
Amended current report
Officer or director change
|
Jun 1, 2022 | May 10, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
May 24, 2022 | May 24, 2022 |
| 8-K/A |
Amended current report
Officer or director change
|
May 13, 2022 | May 10, 2022 |
| 8-K |
Current report
Officer or director change
|
May 11, 2022 | May 10, 2022 |
| 10-Q | Quarterly report | May 4, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 4, 2022 | May 4, 2022 |
| 8-K |
Current report
Shareholder vote results
|
May 3, 2022 | Apr 28, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 11, 2022 | Apr 6, 2022 |
| PX14A6G | Filing | Mar 25, 2022 | — |
| PX14A6G | Filing | Mar 21, 2022 | — |
| DEFA14A | Additional proxy material | Mar 9, 2022 | — |
| DEF 14A | Proxy statement | Mar 9, 2022 | Apr 28, 2022 |
| 10-K | Annual report | Feb 25, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 24, 2022 | Feb 24, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 4, 2022 | Jan 4, 2022 |
| 10-Q | Quarterly report | Nov 4, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2021 | Nov 4, 2021 |
| 10-Q | Quarterly report | Aug 5, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2021 | Aug 5, 2021 |
| 10-Q | Quarterly report | May 6, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 6, 2021 | May 6, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Apr 29, 2021 | Apr 28, 2021 |
| 8-K |
Current report
Other events
|
Apr 28, 2021 | Apr 18, 2021 |
| SEC STAFF LETTER | Filing | Apr 16, 2021 | — |
| 8-K |
Current report
Results of operations
|
Apr 13, 2021 | Apr 13, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 13, 2021 | Apr 13, 2021 |
Showing 122 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- MRNA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1682852
- Former names
- Moderna Therapeutics, Inc. (until Aug 24, 2016)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
- Neurocrine Biosciences Inc NBIX
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.